文献速递妇科

微创与开腹子宫切除术在妊娠滋养细胞疾病中的结局比较

Outcomes of minimally invasive versus open abdominal hysterectomy in patients with gestational trophoblastic disease.
PubMed 文献 · Gynecol Oncol · 2020-12-04

本研究回顾性纳入2009至2018年因妊娠滋养细胞疾病(GTD)行子宫切除术的39例患者,其中微创组22例、开腹组17例。

要点

  • 微创子宫切除术治疗GTD的肿瘤学结局与开腹手术相似。
  • 微创组术中出血量显著少于开腹组,住院时间更短。

核心结论

  • 微创子宫切除术治疗GTD的肿瘤学结局与开腹手术相似,且出血更少、住院时间更短。
  • 无论手术方式如何,总生存率相似。

研究设计与样本

  • 回顾性队列研究,利用机构数据库和肿瘤登记系统识别2009年1月1日至2018年12月31日因GTD行子宫切除术的患者。
  • 共纳入39例患者,微创组22例,开腹组17例。

主要发现

  • 26例(66.7%)子宫切除术为GTD初始治疗,7例(17.9%)因化疗耐药,2例(5.1%)因子宫出血,4例(10.3%)因其他指征。
  • 术后病理包括12例完全性葡萄胎(6例侵袭性)、8例绒毛膜癌、9例胎盘部位滋养细胞肿瘤和9例上皮样滋养细胞肿瘤。

临床怎么用

  • 对于需要子宫切除术的GTD患者,微创手术可作为开腹手术的替代选择,其肿瘤学结局相似且围手术期恢复更优。

局限性

  • 回顾性研究,样本量较小(39例),可能存在选择偏倚。
  • 随访时间两组不一致(微创组中位50.2个月,开腹组79.3个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study is to compare surgical and oncologic outcomes for women undergoing MIH or open abdominal hysterectomy (OAH) for management of gestational trophoblastic disease (GTD). METHODS: Patients who underwent hysterectomy for GTD between January 1, 2009 and December 31, 2018 were identified using an institutional database and tumor registry. Patients were stratified based on indication for and mode of hysterectomy. RESULTS: 39 patients underwent hysterectomy for GTD - 22 MIH and 17 OAH. 26 hysterectomies (66.7%) were performed for primary treatment of GTD, 7 (17.9%) for chemoresistance, 2 (5.1%) for uterine hemorrhage, and 4 (10.3%) for other indications. Mean tumor size (4.2 vs 4.6 cm; p = .81) and operative time (136 vs 163 mins; p = .42) were similar in both groups. MIH was associated with significantly less blood loss (71.5 vs 427.3 ml; p = .03) and shorter hospital stay (1.5 vs 3.9 days, p = .02) than OAH. Postoperative histology comprised 12 complete moles (6 invasive), 8 choriocarcinomas, 9 placental site trophoblastic tumors and 9 epithelioid trophoblastic tumors. Median follow-up was 67.2 months (50.2 MIH, 79.3 OAH; range 11.1-131.2) and there was no difference in remission (81.8% MIH vs 76.5% OAH; p = .68). There were 7 recurrences (4 MIH, 3 OAH) and 3 deaths (2 MIH, 1 OAH). Overall survival was 97.3% at 2 years and 88.5% at 5 years. There was no significant difference in 5-year survival by mode of surgery (MIH 90.9%, OAH 83.3%; p = .40). CONCLUSIONS: Patients undergoing MIH at our centers have similar oncologic outcomes, lower surgical blood loss and shorter hospital stay compared to those undergoing OAH. Overall survival is similar regardless of mode of surgery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Sugrue R, Foley O, Elias KM, et al. Outcomes of minimally invasive versus open abdominal hysterectomy in patients with gestational trophoblastic disease. Gynecol Oncol. 2020. PMID: 33272644. doi:10.1016/j.ygyno.2020.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。